Earnings Scheduled For May 3, 2022
Companies Reporting Before The Bell
• Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
‘Earlier today Kansas lawmakers passed the state’s online sports betting legalization bill, sending it to Gov. Laura Kelly; assuming Kelly signs the bill, Kansas would have legal statewide mobile wagering, possibly as early as this fall’ -Ryan Butler
https://twitter.com/ButlerBets/status/1520074359863357440
10 Consumer Discretionary Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Morgan Stanley Upgrades Penn National Gaming, Says Barstool Provides ‘Unique Customer Acquisition Opportunity’
It's been a brutal year for Penn National Gaming, Inc (NASDAQ: PENN) investors, but the stock got a much-needed boost from a high-profile analyst upgrade on Monday.
‘Maine to Legalize Online Sports Betting Pending Governor’s Signature’ -ActionNetwork Report
https://www.actionnetwork.com/legal-online-sports-betting/maine-passes-bill-to-legalize-online-sports-betting-pending-governor-signature?shortlink=shnkg95v&af_sub1=601628909&c=af-newsletter&pid=af-newsletter&
Truist Securities Maintains Buy on Caesars Entertainment, Lowers Price Target to $105
Truist Securities analyst Barry Jonas maintains Caesars Entertainment (NASDAQ:CZR) with a Buy and lowers the price target from $110 to $105.
B of A Securities Maintains Buy on Caesars Entertainment, Lowers Price Target to $95
B of A Securities analyst Shaun Kelley maintains Caesars Entertainment (NASDAQ:CZR) with a Buy and lowers the price target from $110 to $95.